Minimal supportive treatment in natalizumab-related PML in a MS patient

J Neurol Neurosurg Psychiatry. 2015 Mar;86(3):354-5. doi: 10.1136/jnnp-2014-308154. Epub 2014 Jun 23.

¹ Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospital and Faculty of Medicine of the University of Geneva, Geneva, Switzerland Division of Laboratory Medicine, Department of Genetic and Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland.
² Unit of Neuroimmunology and Multiple Sclerosis, Division of Neurology, Department of Clinical Neurosciences, Geneva University Hospital and Faculty of Medicine of the University of Geneva, Geneva, Switzerland.
³ Division of Laboratory Medicine, Department of Genetic and Laboratory Medicine, Geneva University Hospital, Geneva, Switzerland Laboratory of Virology, Division of Infectious Diseases, University of Geneva Hospitals and University of Geneva Medical School, Geneva, Switzerland.
⁴ Division of Neurology, Department of Clinical Neurosciences, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland Division of Immunology and Allergy, Department of Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
⁵ Department of Radiology & Nuclear Medicine and Image Analysis Centre (IAC), VU University Medical Centre, Amsterdam, The Netherlands.
⁶ Department of Imaging and Medical Informatics, University Hospitals of Geneva and Faculty of Medicine of the University of Geneva, Geneva, Switzerland.

No abstract available

Keywords: MRI; MULTIPLE SCLEROSIS.

Publication types